Stock Price
491.46
Daily Change
-3.08 -0.62%
Monthly
-3.27%
Yearly
4.56%
Q2 Forecast
459.16

Thermo Fisher Scientific reported $9.91B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.44B 27M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 423M 1.06B Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Henry Schein USD 3.25B 110M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
Olympus JPY 233.04B 18.77B Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Veracyte USD 116M 7.24M Dec/2025
Waters USD 661.85M 1.67B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025